Straumann Holding AG (LON:0QMV)
88.54
+0.84 (0.96%)
At close: Oct 21, 2025
Straumann Holding AG Revenue
Straumann Holding AG had revenue of 1.35B CHF in the half year ending June 30, 2025, with 17.86% growth. This brings the company's revenue in the last twelve months to 2.58B, up 7.18% year-over-year. In the year 2024, Straumann Holding AG had annual revenue of 2.50B with 9.98% growth.
Revenue (ttm)
2.58B CHF
Revenue Growth
+7.18%
P/S Ratio
5.68
Revenue / Employee
218.27K CHF
Employees
11,815
Market Cap
13.44B GBP
Revenue Chart
* This company reports financials in CHF.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.50B | 227.21M | 9.98% |
| Dec 31, 2023 | 2.28B | -44.10M | -1.90% |
| Dec 31, 2022 | 2.32B | 298.88M | 14.78% |
| Dec 31, 2021 | 2.02B | 596.05M | 41.80% |
| Dec 31, 2020 | 1.43B | -170.37M | -10.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 31.63B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |